MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
暂无分享,去创建一个
M. J. van den Bent | M. Taphoorn | A. Brandes | T. Gorlia | D. Lacombe | M. Sanson | M. Hegi | W. Dinjens | J. Kros | H. Dubbink | M. Frénay | J. Jeuken | A. Ibdaih | Cathleen R van der Lee-Haarloo